For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Hibercell, Inc.

USPTO Granted Patents = 10

EPO Patents = 2

Trademarks = 1

Forward Citations = 2

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Edward A Kesicki (5 out of 9 patents)

Aleksey I Gerasyuto (3 out of 23 patents)

Nandita Bose (3 out of 12 patents)

4. Johan Lindström (3 out of 3 patents)

5. Lars Boukharta Persson (3 out of 5 patents)

6. Jenny Viklund (3 out of 3 patents)

7. Markus Kristofer Dahlgren (3 out of 8 patents)

8. Eugene R Hickey (3 out of 64 patents)

9. William J Grossman (2 out of 6 patents)

10. Mary A Antonysamy (2 out of 6 patents)

11. Richard M Walsh (2 out of 5 patents)

12. Mariana I Nelson (2 out of 3 patents)

13. Michael E Danielson (2 out of 20 patents)

14. Kyle S Michel (2 out of 4 patents)

15. Matthew Surman (2 out of 20 patents)

10 patents: Sort by Forward Citations

1. 12473296 - Perk inhibiting compounds (2025-11-18),

2. 12390526 - Methods for identifying beta-glucan binding to immune cells (2025-08-19),

3. 12331054 - Perk inhibiting imidazolopyrazine compounds (2025-06-17),

4. 12006332 - Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors (2024-06-11),

5. 11919902 - Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors (2024-03-05),

6. 11815435 - Beta glucan immunopharmacodynamics (2023-11-14),

7. 11667651 - Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors (2023-06-06),

8. 11584763 - Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors (2023-02-21),

9. 11498929 - Chromenopyrimidine derivatives as phosphatidylinsitol phosphate kinase inhibitors (2022-11-15),

10. 11229701 - Methods for identifying beta-glucan binding to immune cells (2022-01-25),

Hibercell is a biotechnology company focused on developing novel therapies for cancer. Our innovative approach harnesses the power of hibernation to target and eradicate cancer cells, providing a potentially game-changing treatment option for patients. With a team of experienced scientists and researchers, we are committed to advancing the field of oncology and improving outcomes for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

10 Patents

#637 in New York, NY

#1,643 in New York

#29,016 in US

#54,349 in the World

New York, NY, United States of America

Hibercell, Inc.

Forward Citations = 2

28 inventors:

Edward A Kesicki (5 out of 9 patents)

Aleksey I Gerasyuto (3 out of 23 patents)

Nandita Bose (3 out of 12 patents)

4. Johan Lindström (3 out of 3 patents)

5. Lars Boukharta Persson (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…